Johnson & Johnson: Coronary Artery Disease trials

The registry lists 17 Coronary Artery Disease studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 10 have results posted.

Phase 2 2Phase 3 3Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)CompletedNCT05966662Not applicableResults posted
• Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery DiseaseActive, not recruitingNCT05755711Results posted
• Disrupt CAD III Post-Approval Study (PAS)CompletedNCT05021757Results posted
• Disrupt CAD IV With the Shockwave Coronary IVL SystemCompletedNCT04151628Not applicableResults posted
• Disrupt CAD III With the Shockwave Coronary IVL SystemCompletedNCT03595176Not applicableResults posted
• Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)CompletedNCT03328949Not applicableResults posted
• Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I)CompletedNCT02650128Not applicableResults posted
• A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureCompletedNCT01877915Phase 3Results posted
• Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion StentCompletedNCT00968019Results posted
• Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)CompletedNCT00543400Phase 2Results posted
• A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) PopulationCompletedNCT06052319
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionActive, not recruitingNCT04763200Not applicable
• Restore EF Observational StudyCompletedNCT04648306
• CoStar Catheter System EvaluationTerminatedNCT00993785Phase 3
• Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPACompletedNCT00653042Phase 2
• Protect II, A Prospective, Multicenter Randomized Controlled TrialTerminatedNCT00562016Phase 3
• Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)TerminatedNCT00440674Phase 4